OMRON Healthcare Co., Ltd. has announced its intention to acquire all shares of MATSUYA R&D Co., Ltd. through a tender offer for shares and other securities based on the Financial Instruments and Exchange Act (Act No. 25 of 1948, including subsequent amendments).
OMRON Healthcare Co., Ltd. announced new initiatives to accelerate its global electrocardiogram (ECG) business strategy, positioning it as a key driver of the company’s cardiovascular vision, Going for ZERO. The strategy, first presented at a press conference held in Tokyo on November 12, 2025, includes additional investment in Indian AI healthtech company Tricog Health India Private Limited and the planned transfer of the Heartnote® ECG service business from JSR Corporation.
OMRON Healthcare Co., Ltd., a global leader in the field of clinically proven, innovative medical equipment for home health monitoring and treatment, today announced that cumulative sales of its nebulizers have surpassed 50 million units.
OMRON Healthcare Co., Ltd. today announced additional investment in India-based AI medtech startup TRICOG HEALTH INDIA PRIVATE LIMITED. This is OMRON Healthcare's second wave of investment in Tricog, following an initial investment in March 2023, further strengthening the partnership to accelerate business growth.
OMRON HEALTHCARE Co., Ltd., (Headquarters: Muko, Kyoto, President & CEO: Ayumu Okada) has signed a Memorandum of Understanding (MOU) with Sky Labs Inc., a South Korean startup (Headquarters: Seongnam City, Republic of Korea; CEO: Jack Byunghwan Lee), with the aim of strengthening collaboration between the two companies.
The Stroke Association and OMRON Healthcare UK have joined together for a three-year partnership to raise awareness of Atrial Fibrillation (AFib) and how it is a major risk factor for stroke.
Welcome to the OMRON Healthcare Corporate Website